LobbyingAvet Pharmaceuticals lobbying by quarter
Avet Pharmaceuticals's latest lobbying report covers Q1 2024, at $30K. Its first report covers Q1 2022; the issues it reports most are Pharmacy.
Avet Pharmaceuticals
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2022 | $30K | 1 |
| Q2 2022 | $0 | 0 |
| Q3 2022 | $0 | 0 |
| Q4 2022 | $30K | 1 |
| Q1 2023 | $30K | 1 |
| Q2 2023 | $30K | 1 |
| Q3 2023 | $30K | 1 |
| Q4 2023 | $30K | 1 |
| Q1 2024 | $30K | 1 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$210K · 7 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)7 reports
- HOUSE OF REPRESENTATIVES7 reports
Firms it paid
| Firm | ||
|---|---|---|
| Rubicon Advisors | $210K | 7 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/07/21for Q1 2022 | Rubicon Advisors | $30K |
| 24/05/08for Q1 2024 | Rubicon Advisors | $30K |
| 24/01/25for Q4 2023 | Rubicon Advisors | $30K |
| 23/10/22for Q3 2023 | Rubicon Advisors | $30K |
| 23/07/23for Q2 2023 | Rubicon Advisors | $30K |
| 23/04/20for Q1 2023 | Rubicon Advisors | $30K |
| 23/01/16for Q4 2022 | Rubicon Advisors | $30K |